Toggle navigation
About Us
Business Areas
R & D
Manufacturing
Beyond Business
Investors
Careers
Contact Us
Investors
Investors > FY 2023-24
Overview
Chairman's Statement
Shareholder Information
Policies or Statutory Documents
IEPF
Debentures
Amalgamation
MOA/AOA
Procedure for Dematerialisation of Shares
Archives
Credit Ratings
CSR
AGM Transcript
Annual Return
Disclosures under Regulation 46 and 62 of SEBI LODR
Financial
2023-24
2022-23
2021-22
2020-21
2019-20
2018-19
2017-18
2016-17
2015-16
2014-15
2013-14
2012-13
2011-12
Investors > FY 2023-24
1. Intimation to Stock Exchange
Intimation of Credit Rating
Press Release – Torrent Pharmaceuticals gets EIR from US FDA for Dahej facility
Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Transcript of Conference call with Analysts / Investors on Financial Results for the quarter ended 30th June, 2023
Newspaper Advertisement Results Q1
Voting Results & Scrutinizer’s Report AGM dated 07-08-2023
Appointment of Nikhil Khattau as an Independent Director of the Company
Alteration of Articles of Association of the Company
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Proceedings of 50th Annual General Meeting of the Company held on 07th August, 2023
Intimation for Presentation to analysts on financial Results for the quarter ended 30th June, 2023
Shareholding Pattern Q1
Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation for Concall with Investors / Analyst Q1_2023-24
Intimation of the Board Meeting dated 07-08-2023
Newspaper advertisement in respect of Annual General Meeting and E-Voting Procedure
Newspaper advertisement regarding Intimation of the 50th AGM of the Company through VC/OAVM facility
Intimation for Trading Window Closure_Q1
USFDA Pre-Approval Inspection of Oral Oncology Manufacturing facility, Gujarat
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation under Regulation 30 of SEBI Listing Regulations_ Final NCLT Order wrt scheme of amalgamation of Curatio Health Care (I) Private Limited with Company
Intimation for Concall with Investors / Analyst Q4_2022-23
Intimation of the Board Meeting dated 30-05-2023
Redemption of Non-Convertible Debentures issued under ISIN:INE685A07108
Redemption of Non-Convertible Debentures issued under ISIN:INE685A07116
2. Quarterly Results
Q1 23-24
Newspaper Advertisement Q1
Q1FY24 Earnings Call Transcript
Press Release
Standalone Result
Consolidated Results
Audio Recording of conference call on Financial Results for the quarter ended June 30, 2023
Details of Nodal Officer
Name
: Chintan Trivedi
Designation
: Company Secretary
E-mail Id
: investorservices@torrentpharma.com
IEPF Authority - Refund web page
IEPF Authority - Refund web page >>